Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LUTO Research is a specialized health communications consultancy and contract research organization (CRO) that focuses on the development and user-centered testing of medical information. Based in Leeds, UK, and now part of The mX Group, the company is a global leader in readability testing, ensuring that patient information leaflets (PILs), packaging, and digital health tools are clear and easy to understand. LUTO employs a rigorous, evidence-based methodology to help pharmaceutical companies comply with regulatory requirements from the EMA, MHRA, and other health authorities. Their services are critical for enhancing patient safety, improving treatment adherence, and bridging the gap between complex medical data and patient comprehension. The company's expertise spans human factors research and health literacy, making them a key partner for pharmaceutical firms during the labeling and commercialization phases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LUTO Research.